Department of Breast Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka-city, Tokyo, 181-8611, Japan.
Department of Breast Surgery, Saitama Medical Center, Saitama, Japan.
Breast Cancer. 2024 Sep;31(5):935-944. doi: 10.1007/s12282-024-01607-0. Epub 2024 Jun 19.
The prognosis in patients with breast cancer with isolated locoregional recurrence (ILRR) without simultaneous distant metastases after immediate breast reconstruction (IBR) remains unknown. We aimed to investigate the prognosis in this patient population.
This multi-institutional retrospective observational study evaluated 3295 patients with primary breast cancer who underwent IBR at 12 Japanese medical facilities between January 1, 2008 and December 31, 2016. The outcome measures were the prognostic factors for ILRR after IBR, 5-year distant metastasis-free interval (DMFI), and 5-year overall survival (OS).
Mastectomy or skin-sparing mastectomy was performed in 3295 patients. ILRR occurred in 70 patients, and the median observation period from ILRR diagnosis was 39.3 months. Of the 70 patients, 9 (12.9%) had axillary lymph node recurrence (ALNR) at the time of ILRR diagnosis. The 5-year DMFI and OS rates after ILRR were 92.4% and 91.2%, respectively. Pathological lymph node metastasis at primary surgery (P = 0.041) and ALNR (P = 0.022) at ILRR were significantly associated with DMFI in the univariate analysis. ALNR was the only independent prognostic factor in the multivariate analysis (P = 0.041). Post-mastectomy radiation therapy (PMRT; P = 0.022) and ALNR (P = 0.043) were significantly associated with OS in the univariate analysis, and both PMRT (P = 0.010) and ALNR (P = 0.028) were independent prognostic factors in the multivariate analysis for OS.
Although patients with breast cancer who had ILRR after IBR have favorable prognosis, ALNR may lead to poor prognosis. To the best of our knowledge, this study is the first to report the prognosis of these patients.
在即时乳房重建(IBR)后发生孤立区域性复发(ILRR)而无同时远处转移的乳腺癌患者的预后尚不清楚。我们旨在研究该患者人群的预后。
本多机构回顾性观察研究评估了 2008 年 1 月 1 日至 2016 年 12 月 31 日期间在 12 家日本医疗机构接受 IBR 的 3295 例原发性乳腺癌患者。主要观察指标为 IBR 后 ILRR 的预后因素、5 年无远处转移间隔(DMFI)和 5 年总生存率(OS)。
3295 例患者中进行了乳房切除术或保留皮肤的乳房切除术。70 例患者发生 ILRR,从 ILRR 诊断到中位观察期为 39.3 个月。在 70 例患者中,9 例(12.9%)在 ILRR 诊断时发生腋窝淋巴结复发(ALNR)。ILRR 后 5 年 DMFI 和 OS 率分别为 92.4%和 91.2%。单因素分析中,原发手术时病理淋巴结转移(P=0.041)和 ILRR 时 ALNR(P=0.022)与 DMFI 显著相关。多因素分析中,ALNR 是唯一的独立预后因素(P=0.041)。乳房切除术术后放疗(PMRT;P=0.022)和 ALNR(P=0.043)与 OS 相关,PMRT(P=0.010)和 ALNR(P=0.028)在多因素分析中也是 OS 的独立预后因素。
尽管 IBR 后发生 ILRR 的乳腺癌患者预后良好,但 ALNR 可能导致不良预后。据我们所知,这项研究首次报道了这些患者的预后。